Drug Type Small molecule drug |
Synonyms + [10] |
Target |
Mechanism DNA inhibitors(DNA inhibitors), DNA cross linking agents |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H32N4O6 |
InChIKeyRWZVMMQNDHPRQD-SFTDATJTSA-N |
CAS Registry232931-57-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 3 | US | 01 Nov 2004 | |
Leukemia | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Acute Myeloid Leukemia | Discovery | US | 01 Apr 2012 | |
Chronic Lymphocytic Leukemia | Discovery | US | 01 Apr 2012 | |
Platinum-Resistant Fallopian Tube Carcinoma | Discovery | US | 01 Jul 2010 | |
Recurrent ovarian cancer | Discovery | US | 01 Jul 2010 | |
recurrent primary peritoneal cavity cancer | Discovery | US | 01 Jul 2010 | |
Acute Promyelocytic Leukemia | Discovery | US | 01 Dec 2005 | |
Recurrent Adult Acute Lymphoblastic Leukemia | Discovery | US | 01 Dec 2005 |
Phase 2 | 19 | laboratory biomarker analysis+SJG-136 | vbmbpqispv(llajyyryjl) = huoqthyqmn fazhkimvig (odheuakctf, oossedktzl - vqzkiqdwzh) View more | - | 25 May 2015 | ||
Phase 1 | - | (yyowqmrwfq) = grade 3 soft tissue edema bjuwpjwzlm (lfxleiiswf ) View more | - | 20 May 2009 | |||
Phase 1 | 14 | xfotqdihkd(ujjywtushc) = eapauiydxa auuwrsojho (lcjrxiyzwn ) View more | - | 20 May 2008 |